Downtrend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend down since May 8 · inside the Ichimoku cloud · RSI 34 · MACD above its signal · at its 52-week low
None of the 29 investors followed here reported a position in GMVDF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a GMVDF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for GMVDF.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -50.0 | 0.0 | 0.0 | 100.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −50.0% | ||
| 2025 | 9900.0 | -98.0 | 0.0 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | -90.0 | 9900.0 | -80.0 | 0.0 | +100.0% |
| 2024 | -7.4 | -47.0 | 15.3 | -1.0 | 15.7 | -48.6 | -16.7 | -91.7 | -60.0 | -50.0 | 0.0 | 0.0 | −99.5% |
| 2023 | 52.1 | -52.3 | -61.8 | -44.8 | -18.4 | -7.2 | -39.5 | -71.3 | -12.2 | -52.4 | -54.7 | 72.8 | −99.3% |
| 2022 | 195.8 | -44.3 | -53.8 | -4.7 | -39.0 | -18.0 | -41.5 | 0.1 | -34.4 | -32.9 | -38.7 | -2.1 | −94.4% |
| 2021 | 95.7 | 0.0 | 11.1 | 0.0 | 1.0 | -27.3 | -27.8 | 35.5 | -37.6 | 9.4 | -0.4 | -31.6 | −27.4% |
| 2020 | -38.9 | -77.3 | 220.0 | 56.3 | 0.0 | -71.9 | 199.0 | -9.6 | -0.3 | 194.7 | 79.3 | -8.0 | +155.6% |
| 2019 | 10.2 | -3.7 | -26.9 | 21.1 | 0.0 | -21.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −26.5% |
| 2018 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.0 | 0.0 | 0.0 | 0.0 | −2.0% |
No analyst coverage for this instrument.
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, the company offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. Further, it provides various accessories for its healthcare products. G Medical Innovations Holdings Ltd was incorporated in 2014 and is based in Rehovot, Israel.
No recent headlines.